Analysts Anticipate Omega Healthcare Investors Inc (OHI) Will Post Quarterly Sales of $219.07 Million
Wall Street brokerages predict that Omega Healthcare Investors Inc (NYSE:OHI) will post sales of $219.07 million for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Omega Healthcare Investors’ earnings, with the highest sales estimate coming in at $220.99 million and the lowest estimate coming in at $217.60 million. Omega Healthcare Investors posted sales of $234.49 million during the same quarter last year, which would indicate a negative year over year growth rate of 6.6%. The business is scheduled to announce its next quarterly earnings report on Wednesday, February 14th.
According to Zacks, analysts expect that Omega Healthcare Investors will report full-year sales of $219.07 million for the current year, with estimates ranging from $905.04 million to $936.00 million. For the next year, analysts expect that the firm will report sales of $929.88 million per share, with estimates ranging from $886.01 million to $958.00 million. Zacks’ sales calculations are a mean average based on a survey of analysts that cover Omega Healthcare Investors.
Several research firms have recently weighed in on OHI. Hilliard Lyons cut shares of Omega Healthcare Investors to a “buy” rating in a report on Wednesday, November 1st. Capital One Financial reiterated an “equal weight” rating on shares of Omega Healthcare Investors in a report on Sunday, October 22nd. ValuEngine upgraded shares of Omega Healthcare Investors from a “hold” rating to a “buy” rating in a report on Friday, December 15th. Vetr cut shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $32.96 price target for the company. in a report on Monday, October 30th. Finally, Zacks Investment Research cut shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a report on Thursday, September 28th. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $32.14.
A number of hedge funds and other institutional investors have recently bought and sold shares of OHI. Bronfman E.L. Rothschild L.P. raised its position in Omega Healthcare Investors by 167.7% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 3,432 shares of the real estate investment trust’s stock worth $113,000 after acquiring an additional 2,150 shares in the last quarter. Ffcm LLC raised its position in Omega Healthcare Investors by 197.6% during the second quarter. Ffcm LLC now owns 3,402 shares of the real estate investment trust’s stock worth $115,000 after acquiring an additional 2,259 shares in the last quarter. Barnett & Company Inc. raised its position in Omega Healthcare Investors by 1,980.0% during the third quarter. Barnett & Company Inc. now owns 5,200 shares of the real estate investment trust’s stock worth $166,000 after acquiring an additional 4,950 shares in the last quarter. Mcmillion Capital Management Inc. bought a new stake in Omega Healthcare Investors during the third quarter worth $201,000. Finally, Timber Hill LLC bought a new stake in Omega Healthcare Investors during the third quarter worth $206,000. 67.95% of the stock is currently owned by hedge funds and other institutional investors.
Omega Healthcare Investors (NYSE OHI) opened at $27.10 on Thursday. The firm has a market cap of $5,350.00, a P/E ratio of 8.36, a PEG ratio of 2.95 and a beta of 0.49. Omega Healthcare Investors has a 1-year low of $26.43 and a 1-year high of $35.14. The company has a quick ratio of 3.40, a current ratio of 3.40 and a debt-to-equity ratio of 1.18.
About Omega Healthcare Investors
Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.